18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results.
Saved in:
| Title: | 18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results. |
|---|---|
| Authors: | Mittlmeier, L. M.1,2 (AUTHOR), Unterrainer, M.2,3 (AUTHOR), Rodler, S.1 (AUTHOR), Todica, A.2 (AUTHOR), Albert, N. L.2 (AUTHOR), Burgard, C.2 (AUTHOR), Cyran, C. C.3 (AUTHOR), Kunz, W. G.3 (AUTHOR), Ricke, J.3 (AUTHOR), Bartenstein, P.2 (AUTHOR), Stief, C. G.1 (AUTHOR), Ilhan, H.2 (AUTHOR), Staehler, M.1,4 (AUTHOR) michael.staehler@med.uni-muenchen.de |
| Source: | European Journal of Nuclear Medicine & Molecular Imaging. Jun2021, Vol. 48 Issue 6, p2031-2037. 7p. 2 Color Photographs, 2 Charts. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 16197070 |
|---|---|
| DOI: | 10.1007/s00259-020-05165-3 |
